These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2539165

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tripeptidyl carboxypeptidase activity of kininase II (angiotensin-converting enzyme).
    Inokuchi J, Nagamatsu A.
    Biochim Biophys Acta; 1981 Dec 15; 662(2):300-7. PubMed ID: 6274413
    [Abstract] [Full Text] [Related]

  • 5. Assessment of kininases in rheumatic diseases and the effect of therapeutic agents.
    Sheikh IA, Kaplan AP.
    Arthritis Rheum; 1987 Feb 15; 30(2):138-45. PubMed ID: 3030335
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE, Chow A, Drapeau G.
    Biochem Pharmacol; 1991 Jul 25; 42(4):721-7. PubMed ID: 1651078
    [Abstract] [Full Text] [Related]

  • 7. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H, Scicli AG, Carretero OA.
    J Pharmacol Exp Ther; 1989 Dec 25; 251(3):817-20. PubMed ID: 2557417
    [Abstract] [Full Text] [Related]

  • 8. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis.
    Proud D, Baumgarten CR, Naclerio RM, Ward PE.
    J Immunol; 1987 Jan 15; 138(2):428-34. PubMed ID: 2878955
    [Abstract] [Full Text] [Related]

  • 9. Studies on the hydrolysis of bradykinin by angiotensin-converting enzyme (kininase II).
    Dorer FE, Stewart JM, Ryan JW.
    Experientia; 1978 Nov 15; 34(11):1436. PubMed ID: 214326
    [Abstract] [Full Text] [Related]

  • 10. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV, Posdnev VF, Komissarova NV, Gomazkov OA.
    Biochemistry (Mosc); 1997 Mar 15; 62(3):247-50. PubMed ID: 9275297
    [Abstract] [Full Text] [Related]

  • 11. Rat tissue kallikrein releases a kallidin-like peptide from rat low-molecular-weight kininogen.
    Hilgenfeldt U, Stannek C, Lukasova M, Schnölzer M, Lewicka S.
    Br J Pharmacol; 2005 Dec 15; 146(7):958-63. PubMed ID: 16231010
    [Abstract] [Full Text] [Related]

  • 12. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor.
    Kaplan AP, Sheikh I, Frendscho MH.
    Int Arch Allergy Appl Immunol; 1985 Dec 15; 77(1-2):64-8. PubMed ID: 2409028
    [Abstract] [Full Text] [Related]

  • 13. Kininases and vascular responses to kinins.
    Babiuk C, Marceau F, St-Pierre S, Regoli D.
    Eur J Pharmacol; 1982 Feb 26; 78(2):167-74. PubMed ID: 6122586
    [Abstract] [Full Text] [Related]

  • 14. Kinins in humans.
    Duncan AM, Kladis A, Jennings GL, Dart AM, Esler M, Campbell DJ.
    Am J Physiol Regul Integr Comp Physiol; 2000 Apr 26; 278(4):R897-904. PubMed ID: 10749777
    [Abstract] [Full Text] [Related]

  • 15. Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.
    Matsumura Y, Maeda H, Kato H.
    Agents Actions; 1990 Mar 26; 29(3-4):172-80. PubMed ID: 2160186
    [Abstract] [Full Text] [Related]

  • 16. Some characteristics of a peptidyl dipeptidase (kininase II) from rat CSF: differential effects of NaCl on the sequential degradation steps of bradykinin.
    Yoshida T, Nosaka S.
    J Neurochem; 1990 Dec 26; 55(6):1861-9. PubMed ID: 2172462
    [Abstract] [Full Text] [Related]

  • 17. Development of a radioimmunoassay for [DES-ARG9]-bradykinin.
    Odya CE, Moreland P, Stewart JM, Barabe J, Regoli DC.
    Biochem Pharmacol; 1983 Jan 15; 32(2):337-42. PubMed ID: 6870961
    [Abstract] [Full Text] [Related]

  • 18. The kininases of Bothrops jararaca plasma.
    Lavras AA, Fichman M, Hiraichi E, Tobo T, Boucault MA.
    Acta Physiol Lat Am; 1980 Jan 15; 30(4):269-74. PubMed ID: 6100945
    [Abstract] [Full Text] [Related]

  • 19. Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists.
    Sangsree S, Brovkovych V, Minshall RD, Skidgel RA.
    Am J Physiol Heart Circ Physiol; 2003 Jun 15; 284(6):H1959-68. PubMed ID: 12623793
    [Abstract] [Full Text] [Related]

  • 20. [Effect of bradkinin-potentiating snake venom peptides and C-terminal pentapeptide fragment of bradkinin on carboxypeptidase N and kiniase activities of human blood serum].
    Paskhina TS, Traleznikova SS, Egorovoa TL, Morozova NA.
    Biokhimiia; 1975 Jun 15; 40(4):844-53. PubMed ID: 173428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.